News & Updates

Part 2 of the HAPPEN* trial shows a 60-percent reduction in the incidence of non-ventilator–associated hospital-acquired pneumonia (NV-HAP) among hospitalized patients with improved oral hygiene.

Some hospitalized children with acute bronchiolitis (AB) and febrile seizures (FB) present with influenza C virus (ICV), which may contribute to more severe clinical presentations, particularly in those with AB, a recent study in Slovenia has found.

A study shows an association between COVID-19 infection and an elevated risk of new-onset respiratory type 2 inflammatory diseases (T2IDs), while vaccination remains protective against such diseases.

Patients with long COVID may derive benefits from treatment with fluvoxamine, which has been shown to reduce fatigue and improve quality of life (QoL) in a study. The use of metformin, on the other hand, shows no significant advantage.

Post-exposure prophylaxis-in-pocket (PIP) appears as effective as pre-exposure prophylaxis (PrEP) in improving quality of life (QoL) of individuals at low risk for HIV but may be a less costly option, according to a matched-control study presented at CROI 2026.